Atıf İçin Kopyala
ALADAĞ KARAKULAK E., Kelkitli E., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY, cilt.37, sa.1, ss.1-4, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
37
Sayı:
1
-
Basım Tarihi:
2020
-
Doi Numarası:
10.4274/tjh.galenos.2019.2019.0157
-
Dergi Adı:
TURKISH JOURNAL OF HEMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.1-4
-
Anahtar Kelimeler:
Graft-versus-host disease, Acute, Chronic, COMPARING METHOTREXATE, ACUTE GVHD, PROPHYLAXIS, CYCLOSPORINE, RISK, TACROLIMUS, TRANSPLANTATION, DIAGNOSIS, AGENT
-
Ondokuz Mayıs Üniversitesi Adresli:
Evet
Özet
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Acute GvHD (aGvHD) is seen after alloHSCT and the incidence of aGvHD is around 30%-50%. aGvHD prophylaxis is essential in patients undergoing allo-HSCT. Initial therapy for aGvHD is steroids. Prognosis is poor in aGvHD patients not responding to steroids. In this article, the pathobiology, clinical findings, prophylaxis, and treatment of aGvHD will be summarized.